Mafosfamide

Jump to: navigation, search

{{Chembox new |ImageFile=Mafosfamide.svg |ImageSize= |IUPACName=2-{[2-[bis(2-chloroethyl)amino]-2-oxo-
1-oxa-3-aza-2λ5-phosphacyclohex-
4-yl}sulfanyl]ethanesulfonic acid |OtherNames= |Section1= ! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers

|-

|

CAS Number

|

|-

|

3D model (JSmol)

|

|-




| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |-

Template:Chembox E number


| MeSH | Mafosfamide |-

|

PubChem CID

|

|-



| colspan="2" |

|- |Section2= ! colspan=2 style="background: #f8eaba; text-align: center;" |Properties

|-

|

Chemical formula

| C9H19Cl2N2O5PS2

|- | Molar mass

| 401.269 g/mol

|- |Section3= }}'

WikiDoc Resources for Mafosfamide

Articles

Most recent articles on Mafosfamide

Most cited articles on Mafosfamide

Review articles on Mafosfamide

Articles on Mafosfamide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mafosfamide

Images of Mafosfamide

Photos of Mafosfamide

Podcasts & MP3s on Mafosfamide

Videos on Mafosfamide

Evidence Based Medicine

Cochrane Collaboration on Mafosfamide

Bandolier on Mafosfamide

TRIP on Mafosfamide

Clinical Trials

Ongoing Trials on Mafosfamide at Clinical Trials.gov

Trial results on Mafosfamide

Clinical Trials on Mafosfamide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mafosfamide

NICE Guidance on Mafosfamide

NHS PRODIGY Guidance

FDA on Mafosfamide

CDC on Mafosfamide

Books

Books on Mafosfamide

News

Mafosfamide in the news

Be alerted to news on Mafosfamide

News trends on Mafosfamide

Commentary

Blogs on Mafosfamide

Definitions

Definitions of Mafosfamide

Patient Resources / Community

Patient resources on Mafosfamide

Discussion groups on Mafosfamide

Patient Handouts on Mafosfamide

Directions to Hospitals Treating Mafosfamide

Risk calculators and risk factors for Mafosfamide

Healthcare Provider Resources

Symptoms of Mafosfamide

Causes & Risk Factors for Mafosfamide

Diagnostic studies for Mafosfamide

Treatment of Mafosfamide

Continuing Medical Education (CME)

CME Programs on Mafosfamide

International

Mafosfamide en Espanol

Mafosfamide en Francais

Business

Mafosfamide in the Marketplace

Patents on Mafosfamide

Experimental / Informatics

List of terms related to Mafosfamide


Overview

Mafosfamide (INN) is an oxazaphosphorine (cyclophosphamide-like) alkylating agent under investigation as a chemotherapeutic. Several Phase I trials have been completed.[1][2]

References

  1. "Intrathecal Mafosfamide". ClinicalTrials.gov. U.S. National Institutes of Health. August 21 2006. Retrieved 2007-07-13. Check date values in: |date= (help) ClinicalTrials.gov Identifier NCT00062881.
  2. "Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors". ClinicalTrials.gov. U.S. National Institutes of Health. February 20 2007. Retrieved 2007-07-13. Check date values in: |date= (help) ClinicalTrials.gov Identifier NCT00031928.



Linked-in.jpg